BSH 2026 - Liverpool

I want to say a big thank you to HaemSTAR for supporting me in attending the 2026 BSH Annual Scientific Meeting in Liverpool where my work was accepted for an E-poster. The conference showcased the broad range of disciplines within Haematology and I’ve chosen a few of my highlights below.

I particularly enjoyed the Obstetric Haematology session where the research behind common clinical scenarios was discussed. For example, how to approach obstetric anaesthesia in the context of thrombocytopenia and progress in setting up a much needed global trial focused on postpartum VTE prevention. Other speakers highlighted the challenges of managing patients in an area lacking high-quality evidence e.g. managing bleeding disorders of unknown cause in pregnancy.

I was encouraged to hear from Yishi Tan about the START UK study in the Thrombosis and Haemostasis top abstracts session. This is a feasibility RCT, currently recruiting, looking at the use of platelet transfusions compared with modified dose anticoagulation in patients with thrombocytopenia and cancer associated thrombosis (CAT). Managing patients with CAT and thrombocytopenia is challenging and it is hoped that START UK data can pave the way for a definitive RCT.

I was also able to attend the HaemSTAR session where it was great to have an update on recent and ongoing HaemSTAR projects. Seeing the engagement with data collection for many of these projects across the UK was really encouraging, and inspiring to see the impact that such collaborative research can have. It was great to hear from Aisha Umar about the process of setting up HaemRYNE and initiating projects in Nigeria. A great example of the perseverance needed to conduct audit and research in challenging circumstances.

I’m grateful to have been able to attend the conference and look forward to BSH 2027.